Cormorant Asset Management, LP Tyra Biosciences, Inc. Transaction History

Cormorant Asset Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.26 - $11.19 $70,715 - $150,438	-13,444 Reduced 1.77%	743,988 $5.32 Million
Q1 2022 May 16, 2022	SELL	$10.03 - $14.09 $827,475 - $1.16 Million	-82,500 Reduced 9.82%	757,432 $8.11 Million
Q4 2021 Feb 14, 2022	SELL	$12.23 - $31.35 $2.81 Million - $7.21 Million	-230,000 Reduced 21.5%	839,932 $11.6 Million
Q3 2021 Nov 15, 2021	BUY	$16.91 - $26.0 $18.1 Million - $27.8 Million	1,069,932 New	1,069,932 $18.2 Million

43.5M

353K

1.1K

Ticker TYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,973,600
Market Cap $646M
Description
Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.